Eli Lilly may reach $2 trillion market cap by 2031
Eli Lilly made history last year by becoming the first healthcare stock to hit a $1 trillion market cap.
The company’s revenue growth has been strong, driven by its GLP-1 products.
Eli Lilly’s tirzepatide is currently the leader in the fast-growing diabetes and weight loss markets, with some estimates suggesting it could reach $62 billion in sales.